JP2019511457A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019511457A5 JP2019511457A5 JP2018538749A JP2018538749A JP2019511457A5 JP 2019511457 A5 JP2019511457 A5 JP 2019511457A5 JP 2018538749 A JP2018538749 A JP 2018538749A JP 2018538749 A JP2018538749 A JP 2018538749A JP 2019511457 A5 JP2019511457 A5 JP 2019511457A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- vwf
- polypeptide
- sdab
- sequence shown
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP16305071.9 | 2016-01-26 | ||
| EP16305071 | 2016-01-26 | ||
| PCT/EP2017/051569 WO2017129630A1 (en) | 2016-01-26 | 2017-01-25 | Anti-vwf d'd3 single-domain antibodies and polypeptides comprising thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019511457A JP2019511457A (ja) | 2019-04-25 |
| JP2019511457A5 true JP2019511457A5 (enExample) | 2020-02-27 |
| JP7096458B2 JP7096458B2 (ja) | 2022-07-06 |
Family
ID=55409787
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018538749A Active JP7096458B2 (ja) | 2016-01-26 | 2017-01-25 | 抗ｖｗｆ ｄ’ｄ３単一ドメイン抗体及びそれを含むポリペプチド |
Country Status (4)
| Country | Link |
|---|---|
| US (3) | US10626186B2 (enExample) |
| EP (1) | EP3408299A1 (enExample) |
| JP (1) | JP7096458B2 (enExample) |
| WO (1) | WO2017129630A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11644471B2 (en) | 2010-09-30 | 2023-05-09 | Ablynx N.V. | Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domains |
| PH12022550313A1 (en) * | 2011-06-23 | 2023-01-23 | Ablynx Nv | Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domains |
| CN108997501A (zh) * | 2018-09-01 | 2018-12-14 | 无锡傲锐东源生物科技有限公司 | 抗vwf蛋白单克隆抗体及其用途 |
| US20250388663A1 (en) | 2022-08-17 | 2025-12-25 | Institut National de la Santé et de la Recherche Médicale | Improved anti-albumin nanobodies and their uses |
| WO2025038813A1 (en) * | 2023-08-16 | 2025-02-20 | Beam Therapeutics Inc. | Cd5-binding polypeptides, compositions comprising the same, and methods for use thereof |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2357974C2 (ru) * | 2003-01-10 | 2009-06-10 | Аблинкс Н.В. | Терапевтические полипептиды, их гомологи, их фрагменты и их применение для модуляции агрегации, опосредованной тромбоцитами |
| DK2444424T3 (en) * | 2005-05-20 | 2018-12-03 | Ablynx Nv | IMPROVED NANOL BODIES (TM) FOR TREATING AGGREGATED MEDICINAL DISORDERS |
| PH12016501323B1 (en) * | 2014-01-10 | 2022-04-29 | Bioverativ Therapeutics Inc | Factor viii chimeric proteins and uses thereof |
-
2017
- 2017-01-25 US US16/072,784 patent/US10626186B2/en active Active
- 2017-01-25 WO PCT/EP2017/051569 patent/WO2017129630A1/en not_active Ceased
- 2017-01-25 EP EP17702059.1A patent/EP3408299A1/en active Pending
- 2017-01-25 JP JP2018538749A patent/JP7096458B2/ja active Active
-
2020
- 2020-03-13 US US16/818,463 patent/US11560436B2/en active Active
-
2022
- 2022-12-20 US US18/068,694 patent/US12559569B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7390345B2 (ja) | アゴニスト性ｔｎｆ受容体結合物質 | |
| US11685789B2 (en) | CD47 antigen-binding molecules | |
| JP2023027258A (ja) | 改善された血清アルブミン結合性免疫グロブリン可変ドメイン | |
| US11208498B2 (en) | Treatment and prevention of cancer using HER3 antigen-binding molecules | |
| TWI825086B (zh) | Her3抗原結合分子 | |
| JP7300385B2 (ja) | 改善された血清アルブミン結合剤 | |
| JP7219220B2 (ja) | 改善された血清アルブミン結合剤 | |
| CN108473563B (zh) | 改进的tnf结合剂 | |
| JP2020506898A5 (enExample) | ||
| JP2019511457A5 (enExample) | ||
| KR102247704B1 (ko) | 항 pd-1/항 her2 천연항체 구조 형태의 헤테로다이머 계의 이중특이성 항체 및 그 제조방법 | |
| WO2018233575A1 (zh) | 阻断型cd47纳米抗体及其用途 | |
| JP2017527272A5 (enExample) | ||
| CN102686611A (zh) | 与“渐进性糖化终产物受体”结合的多肽以及包括所述多肽的组合物和方法 | |
| WO2019109876A1 (zh) | 抗pd‐l1/抗cd47天然抗体结构样异源二聚体形式双特异抗体及其制备 | |
| JP2020501550A5 (enExample) | ||
| JP2018532401A (ja) | 新規抗‐メソテリン抗体およびそれを含む組成物 | |
| JP2011501951A5 (enExample) | ||
| WO2021047559A1 (zh) | 一种断裂型内含肽、使用其的重组多肽的制备方法 | |
| JP2017522903A5 (enExample) | ||
| CA2861307A1 (en) | High affinity sirp-alpha reagents | |
| JP2018537421A5 (enExample) | ||
| JP2019521662A (ja) | 血清アルブミン結合フィブロネクチンｉｉｉ型ドメイン | |
| JP2018505662A (ja) | 血液脳関門輸送分子およびそれらの使用 | |
| JP2021512159A5 (enExample) |